Dergi makalesi Açık Erişim
Oktay, Yavuz; Ulgen, Ege; Can, Ozge; Akyerli, Cemaliye B.; Yuksel, Sirin; Erdemgil, Yigit; Durasi, I. Melis; Henegariu, Octavian Ioan; Nanni, E. Paolo; Selevsek, Nathalie; Grossmann, Jonas; Erson-Omay, E. Zeynep; Bai, Hanwen; Gupta, Manu; Lee, William; Turcan, Sevin; Ozpinar, Aysel; Huse, Jason T.; Sav, M. Aydin; Flanagan, Adrienne; Flanagan, Adrienne
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/59661</identifier> <creators> <creator> <creatorName>Oktay, Yavuz</creatorName> <givenName>Yavuz</givenName> <familyName>Oktay</familyName> </creator> <creator> <creatorName>Ulgen, Ege</creatorName> <givenName>Ege</givenName> <familyName>Ulgen</familyName> <affiliation>Acibadem Univ, Brain Tumor Res Grp, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Can, Ozge</creatorName> <givenName>Ozge</givenName> <familyName>Can</familyName> </creator> <creator> <creatorName>Akyerli, Cemaliye B.</creatorName> <givenName>Cemaliye B.</givenName> <familyName>Akyerli</familyName> </creator> <creator> <creatorName>Yuksel, Sirin</creatorName> <givenName>Sirin</givenName> <familyName>Yuksel</familyName> </creator> <creator> <creatorName>Erdemgil, Yigit</creatorName> <givenName>Yigit</givenName> <familyName>Erdemgil</familyName> <affiliation>Acibadem Univ, Brain Tumor Res Grp, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Durasi, I. Melis</creatorName> <givenName>I. Melis</givenName> <familyName>Durasi</familyName> <affiliation>Sabanci Univ, Fac Engn & Nat Sci, Dept Biol Sci & Bioengn, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Henegariu, Octavian Ioan</creatorName> <givenName>Octavian Ioan</givenName> <familyName>Henegariu</familyName> <affiliation>Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06504 USA</affiliation> </creator> <creator> <creatorName>Nanni, E. Paolo</creatorName> <givenName>E. Paolo</givenName> <familyName>Nanni</familyName> <affiliation>UZH ETH, Funct Genom Ctr Zurich, Zurich, Switzerland</affiliation> </creator> <creator> <creatorName>Selevsek, Nathalie</creatorName> <givenName>Nathalie</givenName> <familyName>Selevsek</familyName> <affiliation>UZH ETH, Funct Genom Ctr Zurich, Zurich, Switzerland</affiliation> </creator> <creator> <creatorName>Grossmann, Jonas</creatorName> <givenName>Jonas</givenName> <familyName>Grossmann</familyName> <affiliation>UZH ETH, Funct Genom Ctr Zurich, Zurich, Switzerland</affiliation> </creator> <creator> <creatorName>Erson-Omay, E. Zeynep</creatorName> <givenName>E. Zeynep</givenName> <familyName>Erson-Omay</familyName> <affiliation>Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06504 USA</affiliation> </creator> <creator> <creatorName>Bai, Hanwen</creatorName> <givenName>Hanwen</givenName> <familyName>Bai</familyName> <affiliation>Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06504 USA</affiliation> </creator> <creator> <creatorName>Gupta, Manu</creatorName> <givenName>Manu</givenName> <familyName>Gupta</familyName> <affiliation>UCL, Canc Inst, 72 Huntley St, London WC1E 6DD, England</affiliation> </creator> <creator> <creatorName>Lee, William</creatorName> <givenName>William</givenName> <familyName>Lee</familyName> <affiliation>Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA</affiliation> </creator> <creator> <creatorName>Turcan, Sevin</creatorName> <givenName>Sevin</givenName> <familyName>Turcan</familyName> <affiliation>Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA</affiliation> </creator> <creator> <creatorName>Ozpinar, Aysel</creatorName> <givenName>Aysel</givenName> <familyName>Ozpinar</familyName> </creator> <creator> <creatorName>Huse, Jason T.</creatorName> <givenName>Jason T.</givenName> <familyName>Huse</familyName> <affiliation>Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA</affiliation> </creator> <creator> <creatorName>Sav, M. Aydin</creatorName> <givenName>M. Aydin</givenName> <familyName>Sav</familyName> </creator> <creator> <creatorName>Flanagan, Adrienne</creatorName> <givenName>Adrienne</givenName> <familyName>Flanagan</familyName> <affiliation>UCL, Canc Inst, 72 Huntley St, London WC1E 6DD, England</affiliation> </creator> <creator> <creatorName>Flanagan, Adrienne</creatorName> <givenName>Adrienne</givenName> <familyName>Flanagan</familyName> <affiliation>UCL, Canc Inst, 72 Huntley St, London WC1E 6DD, England</affiliation> </creator> </creators> <titles> <title>Idh-Mutant Glioma Specific Association Of Rs55705857 Located At 8Q24.21 Involves Myc Deregulation</title> </titles> <publisher>Aperta</publisher> <publicationYear>2016</publicationYear> <dates> <date dateType="Issued">2016-01-01</date> </dates> <resourceType resourceTypeGeneral="Text">Journal article</resourceType> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/59661</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1038/srep27569</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract">The single nucleotide polymorphism rs55705857, located in a non-coding but evolutionarily conserved region at 8q24.21, is strongly associated with IDH-mutant glioma development and was suggested to be a causal variant. However, the molecular mechanism underlying this association has remained unknown. With a case control study in 285 gliomas, 316 healthy controls, 380 systemic cancers, 31 other CNS-tumors, and 120 IDH-mutant cartilaginous tumors, we identified that the association was specific to IDH-mutant gliomas. Odds-ratios were 9.25 (5.17-16.52; 95% CI) for IDH-mutated gliomas and 12.85 (5.94-27.83; 95% CI) for IDH-mutated, 1p/19q co-deleted gliomas. Decreasing strength with increasing anaplasia implied a modulatory effect. No somatic mutations were noted at this locus in 114 blood-tumor pairs, nor was there a copy number difference between risk-allele and only-ancestral allele carriers. CCDC26 RNA-expression was rare and not different between the two groups. There were only minor subtype-specific differences in common glioma driver genes. RNA sequencing and LC-MS/MS comparisons pointed to significantly altered MYC-signaling. Baseline enhancer activity of the conserved region specifically on the MYC promoter and its further positive modulation by the SNP risk-allele was shown in vitro. Our findings implicate MYC deregulation as the underlying cause of the observed association.</description> </descriptions> </resource>
Görüntülenme | 26 |
İndirme | 4 |
Veri hacmi | 1.5 kB |
Tekil görüntülenme | 24 |
Tekil indirme | 4 |